Alessandra Lugaresi
Overview
Explore the profile of Alessandra Lugaresi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
175
Citations
3120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Toscano S, Spelman T, Ozakbas S, Alroughani R, Chisari C, Lo Fermo S, et al.
Neurotherapeutics
. 2025 Feb;
22(2):e00552.
PMID: 39965993
Predicting long-term prognosis and choosing the appropriate therapeutic approach in patients with Multiple Sclerosis (MS) at the time of diagnosis is crucial in view of a personalized medicine. We investigated...
2.
Dhondt R, Dedja K, Aerts S, Van Wijmeersch B, Kalincik T, Reddel S, et al.
Comput Methods Programs Biomed
. 2025 Feb;
263:108624.
PMID: 39965473
Background: Prognostic machine learning research in multiple sclerosis has been mainly focusing on black-box models predicting whether a patients' disability will progress in a fixed number of years. However, as...
3.
Portaccio E, Betti M, de Meo E, Addazio I, Pasto L, Razzolini L, et al.
J Neurol
. 2024 Sep;
271(10):7066-7068.
PMID: 39231861
No abstract available.
4.
Chisari C, Amato M, Di Sapio A, Foschi M, Iaffaldano P, Inglese M, et al.
J Neurol
. 2024 Aug;
271(10):6801-6810.
PMID: 39190108
'Active' and 'non-active' secondary progressive MS (SPMS) have distinct pathophysiological mechanisms and clinical characteristics, but there is still no consensus regarding the frequency of these MS forms in the real-world...
5.
Simone M, Lucisano G, Guerra T, Paolicelli D, Rocca M, Morra V, et al.
J Neurol
. 2024 Aug;
271(10):6782-6790.
PMID: 39179712
Background: To compare Expanded Disability Status Scale (EDSS) trajectories over time between Multiple Sclerosis (MS) groups with pediatric (POMS), adult (AOMS) and late (LOMS) onset, and between patients with and...
6.
De Brouwer E, Becker T, Werthen-Brabants L, Dewulf P, Iliadis D, Dekeyser C, et al.
PLOS Digit Health
. 2024 Jul;
3(7):e0000533.
PMID: 39052668
Background: Disability progression is a key milestone in the disease evolution of people with multiple sclerosis (PwMS). Prediction models of the probability of disability progression have not yet reached the...
7.
Fiscone C, Sighinolfi G, Manners D, Motta L, Venturi G, Panzera I, et al.
Sci Data
. 2024 Jun;
11(1):575.
PMID: 38834674
Multiple sclerosis (MS) is a progressive demyelinating disease impacting the central nervous system. Conventional Magnetic Resonance Imaging (MRI) techniques (e.g., Tw images) help diagnose MS, although they sometimes reveal non-specific...
8.
Portaccio E, Betti M, de Meo E, Addazio I, Pasto L, Razzolini L, et al.
J Neurol
. 2024 May;
271(8):5074-5082.
PMID: 38805052
Objectives: We investigated the occurrence and relative contribution of relapse-associated worsening (RAW) and progression independent of relapse activity (PIRA) to confirmed disability accrual (CDA) and transition to secondary progression (SP)...
9.
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study
Dekeyser C, Hautekeete M, Cambron M, van Pesch V, Patti F, Kuhle J, et al.
J Neurol Neurosurg Psychiatry
. 2024 Apr;
95(11):1021-1031.
PMID: 38569872
Background: It remains unclear whether routine cerebrospinal fluid (CSF) parameters can serve as predictors of multiple sclerosis (MS) disease course. Methods: This large-scale cohort study included persons with MS with...
10.
Lugaresi A, Jokubaitis V, Krysko K
Front Neurol
. 2024 Feb;
15:1368420.
PMID: 38385035
No abstract available.